F. Corona

Factors affecting survival in juvenile systemic sclerosis (2009)

Martini, G., Vittadello, F., Kasapçopur, Ö., Magni Manzoni, S., Corona, F., Duarte-Salazar, C., ...

Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc). Methods. Clinical and laboratory characteristics of patients with...

13.4 High frequency of CNS involvement in linear scleroderma of the face (2008)

Parolin, M, Russo, R, Corona, F, De Oliveira, SKF, Nowakowska, EM, Sztajnbok, F, ...

No abstract available.

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients (2008)

Ferrari, C, Trail, L, Pilkington, C, Maillard, S, Cuttica, R, Katsicas, MM, ...

No abstract available.

7.6 Long-term treatment with glucocorticoids and low bone mass: a longitudinal study in 266 children and adolescents (2008)

Biggioggero, M, Bianchi, ML, Limonta, C, Vai, S, Ghio, L, Colombo, C, ...

No abstract available.

Determination of the Mahalanobis Matrix using Nonparametric Noise Estimations (2008)

A. Lendasse, F. Corona, J. Hao, N. Reyhani, M. Verleysen

Abstract. In this paper, the problem of an optimal transformation of the input space for function approximation problems is addressed. The transformation is defined determining the Mahalanobis matrix...

The Pediatric Rheumatology International Trials Organization American-College-of-Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the definition of improvement (2006)

Ruperto, N., Ravelli, A., Oliveira, S., Alessio, M., Mihaylova, D., Pasic, S., ...

Objective. To use the Pediatric Rheumatology International Trials Organization (PRINTO) core set of outcome measures to develop a validated definition of improvement for the evaluation of response to...

Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases (2004)

Zulian, F., Corona, F., Gerloni, V., Falcini, F., Buoncompagni, A., Scarazatti, M., ...

Objective. We analysed our experience with the use of iloprost for the treatment of critical ischaemic digits (ID) in children with connective tissue diseases (CTD) in order to assess its safety and...

Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases (2003)

Zulian, F., Corona, F., Gerloni, V., Falcini, F., Buoncompagni, A., Scarazatti, M., ...

Objective. We analysed our experience with the use of iloprost for the treatment of critical ischaemic digits (ID) in children with connective tissue diseases (CTD) in order to assess its safety and...

Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases (2003)

Zulian, F., Corona, F., Gerloni, V., Falcini, F., Buoncompagni, A., Scarazatti, M., ...

Objective. We analysed our experience with the use of iloprost for the treatment of critical ischaemic digits (ID) in children with connective tissue diseases (CTD) in order to assess its safety and...

Methotrexate Treatment Every Other Week in Patients with Juvenile Chronic Arthritis (1996)

CIMAZ, R., CORONA, F., SCARAZATTI, M., COHEN, E., BARDARE, M.

Arthritis as a presenting feature of non-Hodgkin's lymphoma

Falcini, F., Bardare, M., Cimaz, R., Lippi, A., Corona, F.

Leukaemia can present with joint swelling in the absence of abnormal haematological findings. Arthritis as a presenting sign of lymphoma, however, is extremely rare. Three children with non-Hodgkin's...